Ebmedicine.net: May 3, 2012. This issue of EM Practice Guidelines Update reviews 2 guidelines that focus on the management of atrial fibrillation (AF) in the emergency department (ED). AF is the most common sustained cardiac rhythm disturbance in adults. It is a risk factor for thromboembolism and congestive heart failure (CHF), and it causes symptoms such […]
A Systematic Review and Meta-Analysis Ahajournals: Mikael Mazighi, MD, PhD; Elena Meseguer, MD; Julien Labreuche, BS; Pierre Amarenco, MD. May 1, 2012. Background and Purpose—Pending the results of randomized controlled trials, the benefit and safety of bridging therapy (combined intravenous and intra-arterial thrombolysis) remain to be determined. The aim of this analysis was to give reliable estimates of efficacy […]
The Society of Thoracic Surgeons: April 30, 2012. STS Clinical Practice Guidelines are intended to assist physicians and other health care providers in clinical decision-making by describing a range of generally acceptable approaches for the diagnosis, management, or prevention of specific diseases or conditions. These guidelines should not be considered inclusive of all proper methods […]
By Ed Susman, Contributing Writer, MedPage Today, Published: April 27, 2012. NEW ORLEANS — The size of the brain bleed appears to determine which medications, if any, are given to atrial fibrillation patients after an intracerebral hemorrhage, a retrospective study showed. Patients with a brain bleed that averaged 2.39 cc were started on warfarin post bleed; those […]
American Heart Association: Correspondence to Jeffrey L. Anderson, MD, Intermountain Medical Center, Cardiovascular Department, 5121 S Cottonwood St, Murray, UT 84107-5701. March 19, 2012. Background—Warfarin is characterized by marked variations in individual dose requirements and a narrow therapeutic window. Pharmacogenetics (PG) could improve dosing efficiency and safety, but clinical trials evidence is meager. Methods and Results—A Randomized […]
Successfully treating heart rhythm disorder improves long-term survival for cardiac surgery patients with atrial fibrillation A recent study conducted by Northwestern Medicine® researchers published in the Journal of Thoracic and Cardiovascular Surgery, reveals that patients with an abnormal heart rhythm known as atrial fibrillation (A-fib) who are undergoing cardiac surgery, have a lower long-term survival rate […]
By Steven Reinberg: HealthDay Reporter WEDNESDAY, April 25 (HealthDay News). When patients with atrial fibrillation stop taking anti-clotting drugs, their stroke risk goes up quickly, new research finds. That risk increases about the same whether they are taking warfarin or a newer, more expensive drug, Xarelto (rivaroxaban). Atrial fibrillation is an abnormal heart rhythm in which the […]
Ajpblive.com: April 18, 2012. Atrial fibrillation (AF) is an independent predictor of stroke and heart failure. Stroke, in particular, is more severe and costly in AF than in non-AF patients. Direct costs to Medicare for AF-related strokes in the first year are estimated to be $2.6 billion. However, 30% to 50% of eligible AF patients receive […]
Ebmedicine.net: May 2012 This issue of EM Practice Guidelines Update reviews 2 guidelines that focus on the management of atrial fibrillation (AF) in the emergency department (ED). AF is the most common sustained cardiac rhythm disturbance in adults. It is a risk factor for thromboembolism and congestive heart failure (CHF), and it causes symptoms such as […]
The Society of Thoracic Surgeons: Hiran C. Fernando, MD, Michael T. Jaklitsch, MD, Garrett L. Walsh, MD, James E. Tisdale, PhD, Charles D. Bridges, MD, ScD, John D. Mitchell, MD, and Joseph B. Shrager, MD Copyright 2011. The Society of Thoracic Surgeons. April 30, 2012. STS Clinical Practice Guidelines are intended to assist physicians and other […]
